New Health Technologies: A UK Perspective; Comment on “Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies”

Document Type : Commentary

Authors

1 Oxford University Hospitals NHS Foundation Trust, Oxford, UK

2 Moorfields Eye Hospital NHS Foundation Trust, London, UK

Abstract

New health technologies require development and evaluation ahead of being incorporated into the patient care pathway. In light of the recent publication by Lehoux et al who discuss the role of entrepreneurs, investors and regulators in providing value to new health technologies, we summarise the processes involved in making new health technologies available for use in the United Kingdom.

Keywords

Main Subjects

References

  1. Parvizi N, Woods K. Regulation of medicines and medical devices: contrasts and similarities. Clin Med (Lond). 2014;14(1):6-12. doi:10.7861/clinmedicine.14-1-6
  2. Sculpher M, Claxton K, Drummond M, McCabe C. Whither trial-based economic evaluation for health care decision making? Health Econ. 2006;15:677-687.
  3. Lehoux P, Miller FA, Daudeline G, Denis JL. Providing value to new health technology: the early contribution of entrepreneurs, investors, and regulatory agencies. Int J Health Policy Manag. 2017; Forthcoming.
  4. National Institute for Health Research. Health Technology Assessment (HTA) Programme http://www.nihr.ac.uk/funding-and-support/funding-for-research-studies/funding-programmes/health-technology-assessment/.  Accessed May 1, 2017.
  5. National Institute for Health Research. Health Technology Assessment (HTA) Programme http://www.nets.nihr.ac.uk/programmes/hta.  Accessed February 22, 2017.
  6. National Institute for Health and Care Excellence website. http://www.nice.org.uk.  Accessed February 21, 2017.
  7. Guidance on Technology Appraisal. National Institute for Health and Care Excellence website. https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-technology-appraisal-guidance.  Accessed February 27, 2017.
  8. Guidance on Highly Specialised Technologies. National Institute for Health and Care Excellence website. https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-highly-specialised-technologies-guidance.  Accessed February 27, 2017.
  9. UK PharmaScan website. https://www.ukpharmascan.org.uk.  Accessed May 1, 2017.
  10. Accelerated Access Review. https://www.gov.uk/government/organisations/accelerated-access-review.   Accessed May 1, 2017
  11. Institution of Mechanical Engineers. Medical Devices and CE Marking the Impact of Brexit. London: The Institution of Mechanical Engineers; 2017. http://www.imeche.org/docs/default-source/1-oscar/reports-policy-statements-and-documents/medical-devices-ce-marking-the-impact-of-brexit.pdf?sfvrsn=0

Files

History

  • Receive Date: 27 February 2017
  • Revise Date: 06 May 2017
  • Accept Date: 06 May 2017
  • First Publish Date: 01 December 2017

Share

How to cite

Statistics